EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Strategies in the Era of Resistance: It Is Too Early to Give Up Antibiotic Therapy

Jennifer M Soares iD, Fernanda Alves, Koteswara Rao Yerra iD, Thalita H N Lima, Nadim Younes, Kate C Blanco, Vanderlei S Bagnato iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188331 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jennifer M Soares und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Anti-Bacterial Agents, Bacteria, Bacterial Infections. Die Arbeit nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas, Governor's University Research Initiative, Chancellor's Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The alarming rise of antimicrobial resistance constitutes a critical global health challenge, threatening the efficacy of conventional antibiotic therapies. Despite this crisis, abandoning antibiotics is premature; instead, a deliberate integration of traditional and emerging antimicrobial approaches is urgently required. The worldwide proliferation of resistant pathogens reflects decades of monotherapy, inadequate stewardship, and the persistent expectation that each new drug class would resolve resistance crises. This review provides a comprehensive overview of the fundamental mechanisms underlying antibiotic action and bacterial resistance, including reduced membrane permeability, efflux pump activity, target modification, and enzymatic inactivation. Building on this foundation, a broad spectrum of innovative antimicrobial strategies designed to complement or enhance antibiotic efficacy was critically examined. These approaches include natural products with intrinsic antimicrobial properties, immunotherapy to modulate host defenses, and antimicrobial photodynamic therapy (aPDT), which utilizes light-activated photosensitizers to generate reactive oxygen species and achieve localized microbial destruction. Notably, aPDT can overcome bacterial resistance, thereby restoring antibiotic effectiveness. Light delivery to infection sites is feasible across nearly all anatomical locations, whether by direct application, fiber optics, or endoscopic methods. Additional promising modalities, such as bacteriophage therapy, metallic and metal-oxide nanoparticles, and antimicrobial peptides (AMPs), are discussed with respect to their mechanisms, advantages, and translational potential. Collectively, these strategies represent a paradigm shift from antibiotic replacement to antibiotic revival and potentiation. By integrating multidisciplinary approaches, it is possible to extend the lifespan of current antibiotics while developing more robust, resistance-resilient therapies. The evidence presented confirms that antibiotic therapy remains an essential component of antimicrobial treatment, provided that it is supported by innovative, complementary technologies. Abandoning antibiotic therapy at this stage is unwarranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, BacterialAnti-Bacterial AgentsBacteriaBacterial InfectionsHumansPhotochemotherapyPhotosensitizing AgentsAnimalsAntimicrobial Peptides

Stichwörter der Autor:innen

alternative therapiesantibiotic resistancephotodynamic therapyphotosensitizers

Substanzen

Anti-Bacterial AgentsPhotosensitizing AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA.
  • São Carlos Institute of Physics, University of São Paulo, São Carlos 13566-590, SP, Brazil.
  • CPRIT Scholar in Cancer Research, Texas A&M University, College Station, TX 77843, USA.

ORCID-Profile: Jennifer M Soares, Koteswara Rao Yerra, Vanderlei S Bagnato

Förderung

  • Cancer Prevention and Research Institute of Texas
  • Governor's University Research Initiative
  • Chancellor's Research Initiative
  • São Paulo Research Foundation
  • National Council for Scientific and Technological Development
  • Brazilian Company for Research and Industrial Innovation
  • Brazilian Federal Agency for Support and Evaluation of Graduate Education
  • Governor’s University Research Initiative

Zitieren

APA

Soares, J. M., Alves, F., Yerra, K. R., Lima, T. H. N., Younes, N., Blanco, K. C., & Bagnato, V. S. (2026). Antimicrobial Strategies in the Era of Resistance: It Is Too Early to Give Up Antibiotic Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188331

Vancouver

Soares JM, Alves F, Yerra KR, Lima THN, Younes N, Blanco KC, et al. Antimicrobial Strategies in the Era of Resistance: It Is Too Early to Give Up Antibiotic Therapy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188331

BibTeX
@article{Soares2026,
  author = {Soares, Jennifer M and Alves, Fernanda and Yerra, Koteswara Rao and Lima, Thalita H N and Younes, Nadim and Blanco, Kate C and Bagnato, Vanderlei S},
  title = {Antimicrobial Strategies in the Era of Resistance: It Is Too Early to Give Up Antibiotic Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188331}
}
Kostenlos starten →